Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E P Goldring

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Hepatology (Baltimore, Md.)|May 4, 2004
Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 miceChristopher E P Goldring, Neil R Kitteringham, Robert Elsby, et al.
Journal of Proteomics|April 20, 2010
Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liverNeil R Kitteringham, Azman Abdullah, Joanne Walsh, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 11, 2015
Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and DetoxicationRowena L C Sison-Young, Dimitra Mitsa, Rosalind E Jenkins, et al.
Medicinal Research Reviews|October 24, 2012
The generation, detection, and effects of reactive drug metabolitesAndrew V Stachulski, Thomas A Baillie, B Kevin Park, et al.
Scientific Reports|May 5, 2016
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and diseaseCatherine C Bell, Delilah F G Hendriks, Sabrina M L Moro, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Hepatology (Baltimore, Md.)|May 4, 2004
Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 miceChristopher E P Goldring, Neil R Kitteringham, Robert Elsby, et al.
Journal of Proteomics|April 20, 2010
Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liverNeil R Kitteringham, Azman Abdullah, Joanne Walsh, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 11, 2015
Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and DetoxicationRowena L C Sison-Young, Dimitra Mitsa, Rosalind E Jenkins, et al.
Medicinal Research Reviews|October 24, 2012
The generation, detection, and effects of reactive drug metabolitesAndrew V Stachulski, Thomas A Baillie, B Kevin Park, et al.
Scientific Reports|May 5, 2016
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and diseaseCatherine C Bell, Delilah F G Hendriks, Sabrina M L Moro, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Pageof 2